Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces

PLoS Pathogens

Volumn 7, Issue 3, 2011, Pages

  Zhao, Gongpu ^a   Ke, Danxia ^a   Vu, Thomas ^a   Ahn, Jinwoo ^a   Shah, Vaibhav B ^b   Yang, Ruifeng ^b   Aiken, Christopher ^b   Charlton, Lisa M ^a   Gronenborn, Angela M ^a   Zhang, Peijun ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; TRIPARTITE MOTIF PROTEIN 5; VIRUS PROTEIN; CAPSID PROTEIN; CARRIER PROTEIN; PROTEIN; TRIM5 PROTEIN, HUMAN; TRIM5(ALPHA) PROTEIN, RHESUS MONKEY; ZINC FINGER PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONCENTRATION RESPONSE; CROSS LINKING; DISULFIDE BOND; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTAGENESIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTEIN TARGETING; RHESUS MONKEY; VIRION; VIRUS CAPSID; VIRUS RECOMBINANT; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MACACA MULATTA; METABOLISM; PATHOGENICITY; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; MIRIDAE;

ANIMALS; CAPSID; CAPSID PROTEINS; CARRIER PROTEINS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MACACA MULATTA; MEMBRANE TRANSPORT PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; ZINC FINGERS;

EID: 79953278280     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002009     Document Type: Article

References (54)

1. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
2. Yap MW, Nisole S, Lynch C, Stoye JP, (2004) Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 101: 10786-10791.
3. Stremlau M, Perron M, Lee M, Li Y, Song B, et al. (2006) Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 103: 5514-5519.
4. Perron MJ, Stremlau M, Lee M, Javanbakht H, Song B, et al. (2007) The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J Virol 81: 2138-2148.
5. Shi J, Aiken C, (2006) Saturation of TRIM5 alpha-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid. Virology 350: 493-500.
6. Sebastian S, Luban J, (2005) TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2: 40.
7. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, et al. (2001) The tripartite motif family identifies cell compartments. EMBO J 20: 2140-2151.
8. Nisole S, Stoye JP, Saib A, (2005) Trim family proteins: Retroviral restriction and antiviral defence. Nat Rev Microbiol 3: 799-808.
9. Ozato K, Shin DM, Chang TH, Morse HC 3rd, (2008) TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 8: 849-860.
10. Stremlau M, Perron M, Welikala S, Sodroski J, (2005) Species-specific variation in the B30.2(SPRY) domain of TRIM5 alpha determines the potency of human immunodeficiency virus restriction. J Virol 79: 3139-3145.
11. Yap MW, Nisole S, Stoye JP, (2005) A single amino acid change in the SPRY domain of human Trim5 alpha leads to HIV-1 restriction. Curr Biol 15: 73-78.
12. Perez-Caballero D, Hatziioannou T, Yang A, Cowan S, Bieniasz PD, (2005) Human tripartite motif 5 alpha domains responsible for retrovirus restriction activity and specificity. J Virol 79: 8969-8978.
13. Sawyer SL, Wu LI, Emerman M, Malik HS, (2005) Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A 102: 2832-2837.
14. Ohkura S, Yap MW, Sheldon T, Stoye JP, (2006) All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J Virol 80: 8554-8565.
15. Song B, Gold B, O'Huigin C, Javanbakht H, Li X, et al. (2005) The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J Virol 79: 6111-6121.
16. James LC, Keeble AH, Khan Z, Rhodes DA, Trowsdale J, (2007) Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc Natl Acad Sci U S A 104: 6200-6205.
17. Li Y, Li X, Stremlau M, Lee M, Sodroski J, (2006) Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J Virol 80: 6738-6744.
18. Mische CC, Javanbakht H, Song B, Diaz-Griffero F, Stremlau M, et al. (2005) Retroviral restriction factor TRIM5alpha is a trimer. J Virol 79: 14446-14450.
19. Javanbakht H, Yuan W, Yeung DF, Song B, Diaz-Griffero F, et al. (2006) Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding. Virology 353: 234-246.
20. Maillard PV, Ecco G, Ortiz M, Trono D, (2010) The specificity of TRIM5alpha-mediated restriction is influenced by its coiled-coil domain. J Virol 84: 5790-801.
21. Li X, Sodroski J, (2008) The TRIM5alpha B-box 2 Domain Promotes Cooperative Binding to the Retroviral Capsid by Mediating Higher-order Self-association. J Virol 82: 11495-502.
22. Diaz-Griffero F, Qin XR, Hayashi F, Kigawa T, Finzi A, et al. (2009) A B-Box 2 Surface Patch Important for TRIM5 alpha Self-Association, Capsid Binding Avidity, and Retrovirus Restriction. J Virol 83: 10737-10751.
23. Javanbakht H, Diaz-Griffero F, Stremlau M, Si Z, Sodroski J, (2005) The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. J Biol Chem 280: 26933-26940.
24. Diaz-Griffero F, Kar A, Perron M, Xiang SH, Javanbakht H, et al. (2007) Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5alpha B-box 2 domain. J Virol 81: 10362-10378.
25. Meroni G, Diez-Roux G, (2005) TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 27: 1147-1157.
26. Perez-Caballero D, Hatziioannou T, Zhang F, Cowan S, Bieniasz PD, (2005) Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J Virol 79: 15567-15572.
27. Wu X, Anderson JL, Campbell EM, Joseph AM, Hope TJ, (2006) Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci U S A 103: 7465-7470.
28. Rold CJ, Aiken C, (2008) Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog 4: e1000074.
29. Berthoux L, Sebastian S, Sayah DM, Luban J, (2005) Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues. J Virol 79: 7883-7888.
30. Munk C, Brandt SM, Lucero G, Landau NR, (2002) A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad Sci U S A 99: 13843-13848.
31. Dodding MP, Bock M, Yap MW, Stoye JP, (2005) Capsid processing requirements for abrogation of Fv1 and Ref1 restriction. J Virol 79: 10571-10577.
32. Langelier CR, Sandrin V, Eckert DM, Christensen DE, Chandrasekaran V, et al. (2008) Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. J Virol 82: 11682-11694.
33. Kar AK, Diaz-Griffero F, Li Y, Li X, Sodroski J, (2008) Biochemical and Biophysical Characterization of a Chimeric TRIM21-TRIM5alpha Protein. J Virol 82: 11669-81.
34. Ganser-Pornillos BK, Chandrasekaran V, Pornillos O, Sodroski JG, Sundquist WI, et al. (2011) Hexagonal assembly of a restricting TRIM5alpha protein. Proc Natl Acad Sci U S A.108: 534-539.
35. Diaz-Griffero F, Li X, Javanbakht H, Song B, Welikala S, et al. (2006) Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 349: 300-315.
36. Li X, Li Y, Stremlau M, Yuan W, Song B, et al. (2006) Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains. J Virol 80: 6198-6206.
37. Black LR, Aiken C, (2010) TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro. J Virol 84: 6564-6569.
38. Byeon IJ, Meng X, Jung J, Zhao G, Yang R, et al. (2009) Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function. Cell 139: 780-790.
39. Owens CM, Song B, Perron MJ, Yang PC, Stremlau M, et al. (2004) Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J Virol 78: 5423-5437.
40. Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, et al. (2009) X-ray structures of the hexameric building block of the HIV capsid. Cell 137: 1282-1292.
41. Ganser-Pornillos BK, Cheng A, Yeager M, (2007) Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell 131: 70-79.
42. Desai A, Mitchison TJ, (1997) Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 13: 83-117.
43. Nogales E, Wang HW, (2006) Structural intermediates in microtubule assembly and disassembly: how and why? Curr Opin Cell Biol 18: 179-184.
44. Fujiwara I, Takahashi S, Tadakuma H, Funatsu T, Ishiwata S, (2002) Microscopic analysis of polymerization dynamics with individual actin filaments. Nat Cell Biol 4: 666-673.
45. Hinshaw JE, Schmid SL, (1995) Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding. Nature 374: 190-192.
46. Forshey BM, von Schwedler U, Sundquist WI, Aiken C, (2002) Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol 76: 5667-5677.
47. Diaz-Griffero F, Kar A, Lee M, Stremlau M, Poeschla E, et al. (2007) Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology 369: 400-410.
48. Yap MW, Mortuza GB, Taylor IA, Stoye JP, (2007) The design of artificial retroviral restriction factors. Virology 365: 302-314.
49. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI, (1999) Assembly and analysis of conical models for the HIV-1 core. Science 283: 80-83.
50. Aiken C, (2009) Cell-free assays for HIV-1 uncoating. Methods Mol Biol 485: 41-53.
51. Gallay P, Hope T, Chin D, Trono D, (1997) HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci U S A 94: 9825-9830.
52. Durocher Y, Perret S, Kamen A, (2002) High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30: E9.
53. Wehrly K, Chesebro B, (1997) p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents. Methods 12: 288-293.
54. Phillips JM, Murray PS, Murray D, Vogt VM, (2008) A molecular switch required for retrovirus assembly participates in the hexagonal immature lattice. EMBO J 27: 1411-1420.